Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

doi:10.3748/wjg.v27.i19.2312

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7613)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

633

WORD

220

HTML

3984

Figures (1-1)

438

Tables (1-3)

203

Sum=5478

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

432

Download

414

Sum=846

Publishing Process of This Article

Item

Count

Browse

647

Download

642

Sum=1289

May 21, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. May 21, 2021; 27(19): 2312-2324
Published online May 21, 2021. doi: 10.3748/wjg.v27.i19.2312

Open in New Tab Full Size Figure Download Figure

Figure 1 The possible immunological mechanism to explain how non-tumor necrosis factor-targeted biologics can induce the development of hepatitis B reactivation. cccDNA: Covalently closed circular DNA; HBV: Hepatitis B virus; IFN: Interferon; IL: Interleukin; T_H17 cells: IL-17 producing T helper cells; T_H1 cells: T helper 1 cells; Tc cells: Cytotoxic T cells.

Citation: Akiyama S, Cotter TG, Sakuraba A. Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics. World J Gastroenterol 2021; 27(19): 2312-2324
URL: https://www.wjgnet.com/1007-9327/full/v27/i19/2312.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i19.2312